BLENREP
100MG INF PLV CSL 1
| SÚKL code | 0249884 |
|---|---|
| Name of the product | BLENREP |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | BLENREP |
| Supplement | 100MG INF PLV CSL 1 |
| Strenght | 100MG |
| Pharmaceutical form | Powder for concentrate for solution for infusion |
| Package | 1 |
| Route | Intravenous use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | BELANTAMAB MAFODOTIN (BELANTAMABUM MAFODOTINUM) |
| ATC group | L01FX15 |
| ATC group name | BELANTAMAB MAFODOTIN |
Marketing authorisation information
| Registration Number | EU/1/20/1474/001 |
|---|---|
| Type of MA | Orphan medicinal products |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | GlaxoSmithKline (Ireland) Limited, Dublin |
| MA Holder country | IRSKO |
cz